Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct 30;139(3):573-86.
doi: 10.1016/j.cell.2009.08.041.

PI3 kinase signals BCR-dependent mature B cell survival

Lakshmi Srinivasan  1 , Yoshiteru Sasaki, Dinis Pedro Calado, Baochun Zhang, Ji Hye Paik, Ronald A DePinho, Jeffrey L Kutok, John F Kearney, Kevin L Otipoby, Klaus Rajewsky
Affiliations

PI3 kinase signals BCR-dependent mature B cell survival

Lakshmi Srinivasan et al. Cell. .

Abstract

Previous work has shown that mature B cells depend upon survival signals delivered to the cells by their antigen receptor (BCR). To identify the molecular nature of this survival signal, we have developed a genetic approach in which ablation of the BCR is combined with the activation of specific, BCR dependent signaling cascades in mature B cells in vivo. Using this system, we provide evidence that the survival of BCR deficient mature B cells can be rescued by a single signaling pathway downstream of the BCR, namely PI3K signaling, with the FOXO1 transcription factor playing a central role.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Constitutively active PI3K rescues BCR negative B cells
(A) Schematic representation of the experimental strategy. (B) Representative FACS analysis of spleen and bone marrow lymphocytes. Numbers represent percentages of cells within the lymphocyte gate or of cells in the gate indicated in the FACS plot. Expression of P110* leads to accumulation of BCRneg mature B cells (B220+, AA4.1−) in the spleen that are GFP positive. The histogram plot in the bone marrow section compares GFP expression in the progenitor gate (B220 low, IgMneg) and the IgMneg mature B cell gate (B220 high, IgMneg) from P110*/+; CD21-cre; B1-8f/JHT mice. (C) FACS analysis of lymphocytes from peritoneal cavity (PEC, top two rows) and lymph nodes (LN, bottom two rows). (D) Comparison of B cell numbers from the spleen of B1-8f/JHT (white bars), CD21-cre; B1-8f/JHT mice (grey bars) and P110*/+; CD21-cre; B1-8f/JHT mice (filled bars), mean and SD of a minimum of 6 mice per genotype.
Figure 2
Figure 2. P110* rescued IgMneg B cells are arranged in follicles in the spleen and are similar to IgMpos B cells
(A) Hematoxylin and Eosin staining of sections of spleen from a wild type C57Bl/6 (B6) and P110*/+; CD21-cre; B1-8f/JHT (PI3K, Fetal liver chimera) mice. (B) Immuno-fluorescent staining of sections of spleen showing part of a single follicle from B1-8f/JHT and P110*/+; CD21-cre; B1-8f/JHT mice. B220, marking all B cells is stained in green, IgM is in red and MOMA1, marking metallophilic macrophages is in blue. (C) Comparison of cell size (FSC), and surface expression of B cell markers B220, CD19, CD23 and CD21 between IgMpos (grey) and IgMneg (black) follicular B cells from spleen of CD21-cre; B1-8f/JHT (top row) and P110*/+; CD21-cre; B1-8f/JHT (bottom row) mice.
Figure 3
Figure 3. P110* rescued IgMneg B cells are resting B cells dependent on BAFF for survival
(A) Comparison of surface expression of activation markers on IgMpos (grey histograms) and IgMneg (black histograms) mature follicular B cells (gated on B220+, AA4.1− and CD23 high) from the spleen of CD21-cre; B1-8f/JHT (left column) and P110*/+; CD21-cre; B1-8f/JHT (right column) mice. (B) Representative FACS plots showing BrdU incorporation in B lymphocytes from spleen after 20 days of BrdU feeding of mice of indicated genotype. The numbers indicate the percentage of BrdU positive or negative cells within the mature B cell fraction (B220+, AA4.1−). (C) Graphical representation of data in B. Also shown is incorporation of Brdu in the IgMpos mature B cells from CD21-cre; B1-8f/JHT and P110*/+; CD21-cre; B1-8f/JHT fetal liver chimeric mice. (D) P110* rescued IgMneg B cells are dependent on BAFF for survival in vitro. IgMpos and IgMneg mature follicular B cells from B1-8f/JHT (B1-8f), CD21-cre; B1-8f/JHT (B1-8cre) and P110*/+; CD21-cre; B1-8f/JHT (P110*) mice were cultured in vitro in the presence (filled markers) or absence (open markers) of BAFF. Data is plotted as percent recovery of viable cells.
Figure 4
Figure 4. Expression of constitutively active IKK2 (IKK2CA) causes limited rescue of IgMneg B cells
(A) Representative FACS analysis of lymphocytes from Spleens of CD21-cre; B1-8f/JHT (left column) and IKK2CA/+; CD21-cre; B1-8f/JHT mice. Numbers represent percentages of cells within the lymphocyte gate or of cells in the gate indicated in the FACS plot. (B) Comparison of B cell numbers from CD21-cre; B1-8f/JHT (open bars) and IKK2CA/+; CD21-cre; B1-8f/JHT (filled bars) mice showing limited rescue of IgMneg B cells by the IKK2CA transgene, mean and SD of 4 mice per genotype. (C) Comparison of rescue of IgMneg B cells by activation of PI3K signaling (left panel) or canonical NF-kB signaling (right panel) in the spleen. Data is plotted as percent of mature B cells (B220+, AA4.1−).
Figure 5
Figure 5. Deletion of Pten rescues BCRneg B cells
Representative FACS analysis of lymphocytes from spleen (A), bone marrow (B), inguinal lymph node (iLN, C) and peritoneal cavity (PEC, D) from CD21-cre; B1-8f/JHT and PtenΔ/f; CD21-cre; B1-8f/JHT mice showing rescue of IgMneg mature B cells by Pten deletion. Numbers represent percentages of cells within the lymphocyte gate or of cells in the gate as indicated in the FACS plot. (E) IgMneg cells rescued by Pten deletion are not activated. Comparison of surface expression of activation markers CD69 and MHC class II on IgMpos (grey histograms) and IgMneg (black histograms) cells from the spleen of CD21-cre; B1-8f/JHT and PtenΔ/f; CD21-cre; B1-8f/JHT mice. (F) Western blot analysis for Pten (top panel) and Actin (bottom panel) in sorted IgMpos and IgMneg mature B cells from spleen of PtenΔ/f; CD21-cre; B1-8f/JHT mice. (G) Immuno-fluorescent staining of sections of spleen showing a single follicle from PtenΔ/f; CD21-cre; B1-8f/JHT mice. B220, marking all B cells is stained in green, IgM is in red and MOMA1, marking metallophilic macrophages is in blue.
Figure 6
Figure 6. P110* rescued IgMneg cells do not up-regulate FOXO targets
Quantitative RT-PCR analysis of FOXO targets in sorted IgMpos and IgMneg mature B cells from spleens of CD21-cre; B1-8f/JHT and P110*/+; CD21-cre; B1-8f/JHT mice. Transcripts shown include BCL2L11 (A), P27/KIP1 (B), AICDA(C) and Rag1 (D). Lanes as indicated in the figure, mean and SD of triplicate experiment are shown.
Figure 7
Figure 7. Survival of resting B cells through BCR is mediated by PI3K-FOXO pathway
(A) FACS analysis of lymphocytes from spleens of B1-8f/JHT (left column), CD21-cre; B1-8f/JHT (middle column) and Foxo1Δ/f; CD21-cre; B1-8f/JHT mice (right column) showing rescue of IgMneg mature B cells by deletion of Foxo1. (B) Comparison of splenic B cell numbers of the mice as indicated in the figure, mean and SD of a minimum of 4 mice per genotype are shown. (C) Immuno-fluorescent staining of splenic sections from Foxo1Δ/f; CD21-cre; B1-8f/JHT mice. (D) FACS analysis of lymphocytes from lymph nodes of the mice as indicated in the figure showing limited rescue of IgMneg B cells in the lymph node upon deletion of Foxo1. (E) Comparison of surface expression of CD62L on IgMpos (grey histogram) and IgMneg (black histogram) B cells from the lymph nodes of mice as indicated in the figure. (F) Western blot analysis of sorted IgMpos and IgMneg B cells from mice as indicated in the figure (Lanes 5–12) for Phospho- Akt (Ser473, Top panel), Akt (middle panel) and Actin (bottom panel). Lanes 1–4 represents mature B cells sorted from B1-8f/JHT mice and contains two fold less protein than lanes 5–12. For a detailed description of this experiment see the Experimental Procedures section.
See this image and copyright information in PMC

References

    1. Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood. 2008;111:1497–1503. - PubMed
    1. Amin RH, Schlissel MS. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol. 2008;9:613–622. - PMC - PubMed
    1. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol. 2003;4:287–294. - PubMed
    1. Bannish G, Fuentes-Panana EM, Cambier JC, Pear WS, Monroe JG. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J Exp Med. 2001;194:1583–1596. - PMC - PubMed
    1. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453–1466. - PMC - PubMed

Publication types

Substances